Daniel Marrero, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4401 Francis Lewis Blvd, Suite L3a, Bayside, NY 11361 Phone: 718-423-3355 Fax: 718-423-3721 |
Adrianne H Mellos, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 44-01 Francis Lewis Boulevard, Suite L3a, Bayside, NY 11361 Phone: 718-423-3355 Fax: 718-423-3721 |
Saji Abraham, M.B.B.S. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4401 Francis Lewis Blvd, Suite L3a, Bayside, NY 11361 Phone: 718-423-3355 Fax: 718-423-3721 |
Frank C Messineo, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 44-01 Francis Lewis Boulevard, Suite L2a, Bayside, NY 11361 Phone: 718-717-0291 Fax: 718-717-0295 |
Barry Bellovin, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2335 Bell Blvd, Bayside, NY 11360 Phone: 718-229-2121 Fax: 718-229-3502 |
Roxana Mihaela Vartolomei, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4401 Francis Lewis Blvd, Suite L3a, Bayside, NY 11361 Phone: 718-423-3355 Fax: 718-423-3721 |
Dr. Omid Kohani, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 21012 Northern Blvd, Bayside, NY 11361 Phone: 718-229-3100 |
Stuart Okin, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 21406 16th Ave, Bayside, NY 11360 Phone: 718-224-3734 |
Martin M Kay, M.D. Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 4401 Francis Lewis Blvd, Suite L3a, Bayside, NY 11361 Phone: 718-423-3355 Fax: 718-423-3721 |
Kaman Ng, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 44-01 Francis Lewis Boulevard, Suite L3a, Bayside, NY 11361 Phone: 718-423-3355 Fax: 718-423-3721 |
News Archive
In a major breakthrough in shellfish management and disease prevention, researchers at the University of New Hampshire have discovered a new method to detect a bacterium that has contaminated New England oyster beds and sickened consumers who ate the contaminated shellfish.
Emisphere Technologies, Inc. and Novo Nordisk A/S today announced that they have entered into an exclusive Development and License Agreement to develop and commercialize oral formulations of Novo Nordisk's insulins, which have the potential of treating diabetes, using Emisphere's Eligen® Technology. This is the second license agreement between the two companies. The first agreement, for the development of oral formulations of GLP-1 receptor agonists, was signed in June 2008, with a potential drug currently in a Phase I clinical trial.
Cells with a mutation in the gene called K-Ras—found in close to 30 percent of all cancers, but mostly those with worst prognosis, such as pancreatic cancer, colon cancer, and lung cancer—behave in ways that subvert the normal mechanisms of cell death, according to a cell-culture study by researchers from Huntsman Cancer Institute (HCI) at the University of Utah.
As chief of the Associated Press' Tokyo bureau, Joseph Coleman wrote a story about an agricultural cooperative in southwestern Japan where organizers put aging residents to work selling leaves and flowers as seasonal garnishes for high-class restaurants.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
› Verified 1 days ago